{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:26:02Z","timestamp":1788207962368,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104276"],"award-info":[{"award-number":["82104276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.exer.2026.111155","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:01:01Z","timestamp":1783119661000},"page":"111155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Understanding the ocular accumulation of mefuparib and its N-dealkylation metabolite: Pharmacokinetics, melanin affinity, and cellular disposition"],"prefix":"10.1016","volume":"271","author":[{"given":"Yan","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.exer.2026.111155_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1167\/iovs.65.12.14","article-title":"Comprehensive pharmacokinetic evaluation of high melanin binder levofloxacin in rabbits shows potential of topical eye drops for posterior segment treatment","volume":"65","author":"Bahrpeyma","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.111155_bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jconrel.2022.05.059","article-title":"Mechanisms of cellular retention of melanin bound drugs: experiments and computational modeling","volume":"348","author":"Bahrpeyma","year":"2022","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.exer.2026.111155_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s40820-024-01477-3","article-title":"Advances in polysaccharide-based microneedle systems for the treatment of ocular diseases","volume":"16","author":"Bao","year":"2024","journal-title":"Nano-Micro Lett."},{"issue":"1\u20132","key":"10.1016\/j.exer.2026.111155_bib4","first-page":"229","article-title":"Binding of chlorpromazine to cultured retinal pigment epithelial cells loaded with melanin","volume":"6","author":"Basu","year":"1989","journal-title":"Lens Eye Toxic. Res."},{"issue":"4","key":"10.1016\/j.exer.2026.111155_bib5","article-title":"Siponimod (BAF312) penetrates, distributes, and acts in the central nervous system: preclinical insights","volume":"7","author":"Bigaud","year":"2021","journal-title":"Mult Scler J. Exp. Transl. Clin."},{"key":"10.1016\/j.exer.2026.111155_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-62703-125-7_4","article-title":"The culture and maintenance of functional retinal pigment epithelial monolayers from adult human eye","volume":"945","author":"Blenkinsop","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.exer.2026.111155_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.11.10.37","article-title":"Danicopan, an oral complement factor D inhibitor, exhibits high and sustained exposure in ocular tissues in preclinical studies","volume":"11","author":"Boyer","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"7","key":"10.1016\/j.exer.2026.111155_bib8","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1021\/jacs.0c12322","article-title":"Unraveling the structure and function of melanin through synthesis","volume":"143","author":"Cao","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.exer.2026.111155_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.exer.2026.111155_bib10","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.18632\/oncotarget.13749","article-title":"Novel PARP1\/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.exer.2026.111155_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16050932","article-title":"PARP inhibitors: strategic use and optimal management in ovarian cancer","volume":"16","author":"Hirschl","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.exer.2026.111155_bib12","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1038\/s41467-023-38056-w","article-title":"Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery","volume":"14","author":"Hsueh","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2026.111155_bib13","article-title":"A simplified method for isolation and culture of retinal pigment epithelial cells from adult mice","volume":"207","author":"Hubal","year":"2024","journal-title":"J. Vis. Exp."},{"issue":"12","key":"10.1016\/j.exer.2026.111155_bib15","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/acs.molpharmaceut.9b00769","article-title":"Establishment of an in Vitro-In vivo correlation for melanin binding and the extension of the ocular half-life of small-molecule drugs","volume":"16","author":"Jakubiak","year":"2019","journal-title":"Mol. Pharm."},{"issue":"22","key":"10.1016\/j.exer.2026.111155_bib14","doi-asserted-by":"crossref","first-page":"10106","DOI":"10.1021\/acs.jmedchem.8b01281","article-title":"Understanding molecular drivers of melanin binding to support rational design of small molecule ophthalmic drugs","volume":"61","author":"Jakubiak","year":"2018","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.exer.2026.111155_bib17","article-title":"Utility of quantitative whole-body autoradiography (QWBA) and oxidative combustion (OC) analysis in the assessment of tissue distribution of [14C]Mefuparib (CVL218) in SD and LE rats","volume":"19","author":"Li","year":"2024","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.exer.2026.111155_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00280-022-04485-5","article-title":"Absorption, distribution, metabolism, and excretion of [14C]Mefuparib (CVL218), a novel PARP1\/2 inhibitor, in rats","volume":"90","author":"Li","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.exer.2026.111155_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2024.101171","article-title":"Ophthalmologic toxicities of antineoplastic agents in genitourinary cancers: mechanisms, management, and clinical implications","volume":"54","author":"Mahadevan","year":"2025","journal-title":"Curr. Probl. Cancer"},{"issue":"11","key":"10.1016\/j.exer.2026.111155_bib19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.exer.2026.111155_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.5b00783","article-title":"Interpretation of ocular melanin drug binding assays. Alternatives to the model of multiple classes of independent sites","volume":"13","author":"Manzanares","year":"2016","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.exer.2026.111155_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jphs.2024.04.001","article-title":"Both hemoglobin and hemin cause damage to retinal pigment epithelium through the iron ion accumulation","volume":"155","author":"Muramatsu","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.exer.2026.111155_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/OTT.S499226","article-title":"The landscape of PARP inhibitors in solid cancers","volume":"18","author":"Muzzana","year":"2025","journal-title":"OncoTargets Ther."},{"issue":"5","key":"10.1016\/j.exer.2026.111155_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13050678","article-title":"Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases","volume":"13","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exer.2026.111155_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Contr. Release"},{"issue":"207","key":"10.1016\/j.exer.2026.111155_bib25","doi-asserted-by":"crossref","DOI":"10.3791\/66079","article-title":"Isolation of primary porcine retinal pigment epithelial cells for in vitro modeling","author":"Paterson","year":"2024","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.exer.2026.111155_bib26","first-page":"405","article-title":"The reaction of uveal pigment in vitro with polycyclic compounds","volume":"3","author":"Potts","year":"1964","journal-title":"Investig. Ophthalmol."},{"key":"10.1016\/j.exer.2026.111155_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2023.07.028","article-title":"Selective drug delivery to the retinal cells: biological barriers and avenues","volume":"361","author":"Ramsay","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.exer.2026.111155_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2018.05.034","article-title":"Melanin targeting for intracellular drug delivery: quantification of bound and free drug in retinal pigment epithelial cells","volume":"283","author":"Rimpel\u00e4","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.exer.2026.111155_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpel\u00e4","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.exer.2026.111155_bib28","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1021\/acs.molpharmaceut.5b00787","article-title":"Drug distribution to retinal pigment epithelium: studies on melanin binding, cellular kinetics, and single photon emission computed tomography\/computed tomography imaging","volume":"13","author":"Rimpel\u00e4","year":"2016","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.exer.2026.111155_bib31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1167\/iovs.12-10169","article-title":"Assessing a novel depot delivery strategy for noninvasive administration of VEGF\/PDGF RTK inhibitors for ocular neovascular disease","volume":"54","author":"Robbie","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.exer.2026.111155_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3565(25)30482-9","article-title":"Iris pigmentation and atropine mydriasis","volume":"197","author":"Salazar","year":"1976","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.exer.2026.111155_bib33","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.toxrep.2014.10.019","article-title":"Chloroquine and hydroxychloroquine binding to melanin: some possible consequences for pathologies","volume":"1","author":"Schroeder","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.exer.2026.111155_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-3-031-72230-1_50","article-title":"Drug-induced retinal toxicity","volume":"1467","author":"Vyas","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.exer.2026.111155_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.909182","article-title":"Development of a novel knockout model of retinitis pigmentosa using Pde6b-knockout long-Evans rats","volume":"9","author":"Yang","year":"2022","journal-title":"Front. Med."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:03:29Z","timestamp":1788206609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0014483526003118"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.111155","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the ocular accumulation of mefuparib and its N-dealkylation metabolite: Pharmacokinetics, melanin affinity, and cellular disposition","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.111155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111155"}}